SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967; 16: 178222. In Japanese.
  • 2
    Galeotti C, Bayry J, Kone-Paut I, Kaveri SV. Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin. Autoimmun Rev 2010; 9: 4418.
  • 3
    Burns JC. Kawasaki disease update. Indian J Pediatr 2009; 76: 716.
  • 4
    Kim DS. Kawasaki disease. Yonsei Med J 2006; 47: 75972.
  • 5
    Furukawa S, Matsubara T, Jujoh K, Yone K, Sugawara T, Sasai K, et al. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 1988; 48: 24751.
  • 6
    Kriegler M, Perez C, DeFay K, Albert I, Lu SD. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 1988; 53: 4553.
  • 7
    Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003; 374: 120.
  • 8
    Smith AJ, Humphries SE. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 2009; 20: 4359.
  • 9
    Weng KP, Hsieh KS, Hwang YT, Huang SH, Lai TJ, Yuh YS, et al. IL-10 polymorphisms are associated with coronary artery lesions in acute stage of Kawasaki disease. Circ J 2010; 74: 9839.
  • 10
    Furukawa S, Imai K, Matsubara T, Yone K, Yachi A, Okumura K, et al. Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. Arthritis Rheum 1992; 35: 6727.
  • 11
    Weng KP, Ho TY, Chiao YH, Cheng JT, Hsieh KS, Huang SH, et al. Cytokine genetic polymorphisms and susceptibility to Kawasaki disease in Taiwanese children. Circ J 2010; 74: 272633.
  • 12
    Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 2005; 47: 2324.
  • 13
    Iwashima S, Kimura M, Ishikawa T, Ohzeki T. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study. Clin Drug Investig 2011; 31: 1919.
  • 14
    Fu S, Gong F, Xie C, Zhu W, Wang W, Shen H, et al. S100A12 on circulating endothelial cells surface in children with Kawasaki disease. Pediatr Res 2010; 68: 1658.
  • 15
    Chen R, Lowe L, Wilson JD, Crowther E, Tzeggai K, Bishop JE, et al. Simultaneous quantification of six human cytokines in a single sample using microparticle-based flow cytometric technology. Clin Chem 1999; 45: 16934.
  • 16
    Gupta M, Noel GJ, Schaefer M, Friedman D, Bussel J, Johann-Liang R. Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment. J Clin Immunol 2001; 21: 1939.
  • 17
    Hsueh KC, Lin YJ, Chang JS, Wan L, Tsai YH, Tsai CH, et al. Association of interleukin-10 A-592C polymorphism in Taiwanese children with Kawasaki disease. J Korean Med Sci 2009; 24: 43842.
  • 18
    Jin HS, Kim HB, Kim BS, Lee JK, Seo EJ, Yoo HW, et al. The IL-10 (−627 A/C) promoter polymorphism may be associated with coronary aneurysms and low serum albumin in Korean children with Kawasaki disease. Pediatr Res 2007; 61: 5847.
  • 19
    Matsubara T, Katayama K, Matsuoka T, Fujiwara M, Koga M, Furukawa S. Decreased interferon-γ (IFN-γ)-producing T cells in patients with acute Kawasaki disease. Clin Exp Immunol 1999; 116: 5547.
    Direct Link:
  • 20
    Chen J, Liu XS. Development and function of IL-10 IFN-γ-secreting CD4+ T cells. J Leukoc Biol 2009; 86: 130510.
  • 21
    Hahn Y, Kim Y, Jo S, Han H. Reduced frequencies of peripheral interferon-γ-producing CD4+ and CD4- cells during acute Kawasaki disease. Int Arch Allergy Immunol 2000; 122: 2938.
  • 22
    Chan WC, Duong TT, Yeung RS. Presence of IFN-γ does not indicate its necessity for induction of coronary arteritis in an animal model of Kawasaki disease. J Immunol 2004; 173: 3492503.
  • 23
    Miura M, Kohno K, Ohki H, Yoshiba S, Sugaya A, Satoh M. Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin. Eur J Pediatr 2008; 167: 111923.
  • 24
    Hui-Yuen JS, Duong TT, Yeung RS. TNF-α is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J Immunol 2006; 176: 6294301.
  • 25
    Hirao J, Hibi S, Andoh T, Ichimura T. High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol 1997; 112: 1526.
  • 26
    Kimura J, Takada H, Nomura A, Ohno T, Mizuno Y, Saito M, et al. Th1 and Th2 cytokine production is suppressed at the level of transcriptional regulation in Kawasaki disease. Clin Exp Immunol 2004; 137: 4449.